AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32823218 — intervention group
Group type: EXPERIMENTAL
Intervention: Single parenteral dose of 300,000 IU of vitamin D
Number of subjects: 46
Study 32823218 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 46
Study 36263570 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent aerobic exercise group (IAEG)
Number of subjects: 36
Study 36263570 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study 36263570 — intervention group
Group type: COMPARATOR
Intervention: Intermittent aerobic exercise group (IAEG) vs Control group (CG)
Number of subjects: 36
Study 32962523 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) + Resistance Training (RT) 3x/week
Number of subjects: 26
Study 32962523 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous High-Intensity Aerobic Exercise (AEX) + RT 3x/week
Number of subjects: 26
Study 32962523 — intervention group
Group type: COMPARATOR
Intervention: Both HIIT and AEX
Number of subjects: 26
Study 32379661 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative therapy (short-term psychodynamic psychotherapy & cognitive-behavioral therapy)
Number of subjects: 36
Study 32379661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 36
Study 32379661 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 36
Study 35354617 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus immersive virtual reality (VR) experience
Number of subjects: 80
Study 35354617 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 80
Study 33795561 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 267
Study 33795561 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 267
Study 33795561 — intervention group
Group type: COMPARATOR
Intervention: Abrocitinib 30 mg
Number of subjects: 267
Study 33795561 — intervention group
Group type: COMPARATOR
Intervention: Abrocitinib 10 mg
Number of subjects: 267
Study 33795561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 36207050 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5×10^6 IU of low-dose IL-2
Number of subjects: 60
Study 36207050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33950931 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 0
Study 33950931 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 0
Study 32172199 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-free survival (DFS)
Number of subjects: 24
Study 32172199 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrence-free survival (RFS)
Number of subjects: 24
Study 32172199 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to recurrence (TTR)
Number of subjects: 24
Study 34427941 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg tapentadol
Number of subjects: 21
Study 34427941 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oxycodone
Number of subjects: 21
Study 34427941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 35713352 — intervention group
Group type: EXPERIMENTAL
Intervention: Dignity therapy (DT) sessions using the Empathic Communication Coding System (ECCS-DT)
Number of subjects: 25
Study 34231244 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak epileptiform burden
Number of subjects: 1967
Study 34231244 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, Acute Physiology and Chronic Health Evaluation II score, seizure on presentation, diagnosis of hypoxic–ischemic encephalopathy
Number of subjects: 1967
Study 34231244 — intervention group
Group type: EXPERIMENTAL
Intervention: Model calibration error across 3 strata based on the time interval between last EEG measurement and discharge
Number of subjects: 1967
Study 33797462 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety Advisor application usage
Number of subjects: 181
Study 33797462 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety Advisor application users
Number of subjects: 181
Study 34689056 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 63
Study 34689056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 33546068 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined general anesthesia and SSPB group (S group)
Number of subjects: 63
Study 33546068 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined general anesthesia and DSPB group (D group)
Number of subjects: 63
Study 33546068 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia group (P group)
Number of subjects: 63
Study 33130645 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed treatment protocol including drugs affecting pathogenetic mechanisms of the disease.
Number of subjects: 60
Study 33130645 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed treatment protocol
Number of subjects: 60
Study 32972467 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive-behavioral intervention delivered through a smartphone app
Number of subjects: 392
Study 32972467 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 392
Study 33465273 — intervention group
Group type: EXPERIMENTAL
Intervention: VM202
Number of subjects: 500
Study 33465273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 32537656 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal health system specialty pharmacy (HSSP)
Number of subjects: 204
Study 32537656 — intervention group
Group type: COMPARATOR
Intervention: External specialty pharmacies
Number of subjects: 204
Study 34547270 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 1:200000 epinephrine
Number of subjects: 28
Study 34547270 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 28
Study 34532749 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanxin Danshen Dropping Pill (0.4 g, thrice daily) and Andrographis tablet (0.2 g, thrice daily) for 4 weeks
Number of subjects: 154
Study 34532749 — intervention group
Group type: COMPARATOR
Intervention: Guanxin Danshen Dropping Pill (0.4 g, thrice daily)
Number of subjects: 154
Study 35019665 — intervention group
Group type: EXPERIMENTAL
Intervention: Alloplastic bone grafts at third molar extraction sites
Number of subjects: 27
Study 35019665 — intervention group
Group type: COMPARATOR
Intervention: Nongrafted sites
Number of subjects: 27
Study 32196856 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular hyosine n-butyl bromide (HBB) 40 mg (2 mL)
Number of subjects: 124
Study 32196856 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 mL of water for injection)
Number of subjects: 124
Study 35593966 — intervention group
Group type: EXPERIMENTAL
Intervention: REThink therapeutic game
Number of subjects: 142
Study 35593966 — intervention group
Group type: COMPARATOR
Intervention: Standard face‐to‐face prevention program
Number of subjects: 142
Study 35593966 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (transformed into care as usual at follow-up)
Number of subjects: 142
Study 32928580 — intervention group
Group type: COMPARATOR
Intervention: Standard Care Group (SCG)
Number of subjects: 180
Study 32928580 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Group (MDG)
Number of subjects: 180
Study 32928580 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Lifestyle Group (MLG)
Number of subjects: 180
Study 32464878 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Ischemic Heart Preservation (NIHP)
Number of subjects: 37
Study 32464878 — intervention group
Group type: COMPARATOR
Intervention: Static Cold Storage (SCS)
Number of subjects: 37
Study 33522342 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (2 × 20 mg p.o) in addition to aspirin (80 mg p.o) and calcium (1 g p.o) from 14 to 20 weeks until delivery
Number of subjects: 38
Study 33522342 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 33892830 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish applied biannually
Number of subjects: 5397
Study 33892830 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fluoride varnish)
Number of subjects: 5397
Study 36052454 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT) for 12 weeks
Number of subjects: 30
Study 36052454 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 30
Study 33825498 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mSv CT (n = 1535 patients)
Number of subjects: 3074
Study 33825498 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose CT (CDCT) (n = 1539 patients)
Number of subjects: 3074
Study 36004716 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Bacillus clausii UBBC‐07 (2×10^9 per 5 ml vial) taken daily twice for three months
Number of subjects: 90
Study 36004716 — intervention group
Group type: COMPARATOR
Intervention: Placebo suspension
Number of subjects: 90
Study 36004716 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Bacillus clausii UBBC‐07
Number of subjects: 90
Study 33563473 — intervention group
Group type: EXPERIMENTAL
Intervention: Central venous pressure (CVP) monitoring
Number of subjects: 2029
Study 33563473 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid administration during KT
Number of subjects: 2029
Study 33883156 — intervention group
Group type: EXPERIMENTAL
Intervention: Food insecure households (newly or consistently)
Number of subjects: 569
Study 33883156 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent food insecurity
Number of subjects: 569
Study 33883156 — intervention group
Group type: EXPERIMENTAL
Intervention: Households changing from food secure to insecure
Number of subjects: 569
Study 34610332 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy in combination with surgery
Number of subjects: 280
Study 34610332 — intervention group
Group type: COMPARATOR
Intervention: Upfront surgery
Number of subjects: 280
Study 34610332 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 280
Study 34269087 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 0
Study 34269087 — intervention group
Group type: EXPERIMENTAL
Intervention: Propensity score weighting
Number of subjects: 0
Study 34269087 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-interaction propensity model
Number of subjects: 0
Study 32602373 — intervention group
Group type: EXPERIMENTAL
Intervention: Small needle-knife therapy (1 to 3 treatments over seven days)
Number of subjects: 83
Study 32602373 — intervention group
Group type: COMPARATOR
Intervention: Oral Celecoxib
Number of subjects: 83
Study 34666553 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 0
Study 34666553 — intervention group
Group type: COMPARATOR
Intervention: Causal Decision-Analytic Markov Model (CDAMM)
Number of subjects: 0
Study 32870471 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly semaglutide 0.5 mg
Number of subjects: 0
Study 32870471 — intervention group
Group type: COMPARATOR
Intervention: Once-weekly dulaglutide 0.75 mg
Number of subjects: 0
Study 35174541 — intervention group
Group type: EXPERIMENTAL
Intervention: Endo-wing-assisted colonoscopy (EAC)
Number of subjects: 800
Study 35174541 — intervention group
Group type: COMPARATOR
Intervention: Transparent hood-assisted colonoscopy (TAC)
Number of subjects: 800
Study 33737200 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered behavioral diabetes self-care program over the phone (6 months, 11 sessions)
Number of subjects: 403
Study 33737200 — intervention group
Group type: COMPARATOR
Intervention: Self-paced general health program
Number of subjects: 403
Study 33737200 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered behavioral diabetes self-care program over the phone
Number of subjects: 403
Study 33599688 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with carboplatin
Number of subjects: 634
Study 33599688 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy without carboplatin
Number of subjects: 634
Study 32357903 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support intervention
Number of subjects: 558
Study 32357903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis of peer support intervention
Number of subjects: 558
Study 33675133 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (no poor risk features; surveillance)
Number of subjects: 54
Study 33675133 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (intermediate pathologic risk factors; 50-Gy radiotherapy)
Number of subjects: 54
Study 33675133 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (poor prognostic pathologic factors; concurrent 56-Gy chemoradiotherapy with weekly cisplatin)
Number of subjects: 54
Study 33675133 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 54
Study 33675133 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional failures (LRFs)
Number of subjects: 54
Study 32396568 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological symptoms assessed using Brief Symptom Inventory (BSI) and Global Severity Index (GSI)
Number of subjects: 130
Study 32396568 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-traumatic stress symptoms assessed using Impact of Event Scale-Revised (IES-R)
Number of subjects: 130
Study 32396568 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective quality of life assessed using Manchester Short Assessment of Quality of Life (MANSA)
Number of subjects: 130
Study 35021171 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mouthrinse
Number of subjects: 51
Study 35021171 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthrinse (0.12%)
Number of subjects: 51
Study 35021171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride mouthrinse (0.05%)
Number of subjects: 51
Study 35695362 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultravist
Number of subjects: 46
Study 35695362 — intervention group
Group type: EXPERIMENTAL
Intervention: Visipaque
Number of subjects: 46
Study 32822510 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced Prolonged Position (FPP)
Number of subjects: 221
Study 32822510 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 221
Study 33534333 — intervention group
Group type: EXPERIMENTAL
Intervention: T4H program (home helpers assisting older adults with exercise coaching using IT devices)
Number of subjects: 35
Study 33534333 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard home help)
Number of subjects: 35
Study 32214062 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-based mirror therapy (TBMT) for 25 minutes per day for 25 days
Number of subjects: 30
Study 32214062 — intervention group
Group type: COMPARATOR
Intervention: Occupational therapy (control group) for 25 minutes per day for 25 days
Number of subjects: 30
Study 34196380 — intervention group
Group type: EXPERIMENTAL
Intervention: auto-EPAP
Number of subjects: 50
Study 34196380 — intervention group
Group type: COMPARATOR
Intervention: fixed-EPAP
Number of subjects: 50
Study 33609104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 16400
Study 33609104 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 16400
Study 33609104 — intervention group
Group type: EXPERIMENTAL
Intervention: White blood cell count
Number of subjects: 16400
Study 33609104 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil count
Number of subjects: 16400
Study 33609104 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocyte count
Number of subjects: 16400
Study 33609104 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein
Number of subjects: 16400
Study 33609104 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-6
Number of subjects: 16400
Study 36179066 — intervention group
Group type: EXPERIMENTAL
Intervention: UP165 (corn leaf extract) 250 mg/day
Number of subjects: 45
Study 36179066 — intervention group
Group type: EXPERIMENTAL
Intervention: UP165 (corn leaf extract) 500 mg/day
Number of subjects: 45
Study 36179066 — intervention group
Group type: EXPERIMENTAL
Intervention: UP165 (corn leaf extract)
Number of subjects: 45
Study 32594774 — intervention group
Group type: EXPERIMENTAL
Intervention: Glittre-ADL test without the backpack
Number of subjects: 40
Study 32594774 — intervention group
Group type: COMPARATOR
Intervention: Glittre-ADL test with the backpack
Number of subjects: 40
Study 35162750 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent Aquatic Training (MAT)
Number of subjects: 0
Study 35162750 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34237743 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day training on drinking and micturition habits
Number of subjects: 0
Study 35389681 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPS-5
Number of subjects: 198
Study 35389681 — intervention group
Group type: EXPERIMENTAL
Intervention: PCL-5
Number of subjects: 198
Study 35389681 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CAPS-5 and PCL-5
Number of subjects: 198
Study 35301135 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic sleep positional therapy wearable device
Number of subjects: 100
Study 35301135 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 100
Study 35390172 — intervention group
Group type: EXPERIMENTAL
Intervention: MK‐1092 (4-64 nmol/kg)
Number of subjects: 0
Study 35390172 — intervention group
Group type: EXPERIMENTAL
Intervention: MK‐1092 (≥ 16 nmol/kg)
Number of subjects: 0
Study 35390172 — intervention group
Group type: EXPERIMENTAL
Intervention: MK‐1092
Number of subjects: 0
Study 33121332 — intervention group
Group type: EXPERIMENTAL
Intervention: BPAUM score (body mass index, proteinuria, age, uric acid, mean arterial pressure)
Number of subjects: 907
Study 32395836 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatar education application
Number of subjects: 36
Study 32395836 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study 35522187 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfluidic sperm preparation
Number of subjects: 386
Study 35522187 — intervention group
Group type: COMPARATOR
Intervention: Density-gradient centrifugation (control)
Number of subjects: 386
Study 33377568 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow
Number of subjects: 563
Study 33377568 — intervention group
Group type: COMPARATOR
Intervention: Standard-oxygen
Number of subjects: 563
Study 33377568 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow (in children with obstructive airway disease)
Number of subjects: 563
Study 33377568 — intervention group
Group type: COMPARATOR
Intervention: Standard-oxygen (in children with obstructive airway disease)
Number of subjects: 563
Study 33983785 — intervention group
Group type: EXPERIMENTAL
Intervention: ImPACT cognitive tests (current five-composite structure)
Number of subjects: 36091
Study 33983785 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-factor model identified through CFA
Number of subjects: 36091
Study 33983785 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis (EFA)
Number of subjects: 36091
Study 32221294 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerobutyricum soehngenii
Number of subjects: 24
Study 35264154 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 33
Study 33525925 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasacral transcutaneous electrical nerve stimulation
Number of subjects: 40
Study 33525925 — intervention group
Group type: COMPARATOR
Intervention: Sham electrotherapy
Number of subjects: 40
Study 32817311 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 400 μg oral supplementation once daily for a year
Number of subjects: 159
Study 32817311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 33438441 — intervention group
Group type: EXPERIMENTAL
Intervention: DESCANT intervention (personalised care package with memory aids and training)
Number of subjects: 128
Study 33438441 — intervention group
Group type: EXPERIMENTAL
Intervention: Orientation clocks (91%), whiteboards (60%), calendars (43%), notebooks (32%)
Number of subjects: 128
Study 33438441 — intervention group
Group type: EXPERIMENTAL
Intervention: DESCANT intervention
Number of subjects: 128
Study 34186138 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates training combined with biofeedback training
Number of subjects: 42
Study 34186138 — intervention group
Group type: EXPERIMENTAL
Intervention: Kegel training combined with biofeedback training
Number of subjects: 42
Study 34186138 — intervention group
Group type: COMPARATOR
Intervention: Kegel training alone
Number of subjects: 42
Study 32771433 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal mucosa graft
Number of subjects: 40
Study 32771433 — intervention group
Group type: COMPARATOR
Intervention: Temporalis fascia graft
Number of subjects: 40
Study 32683215 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand Arm Bimanual Intensive Therapy (HABIT)
Number of subjects: 16
Study 32683215 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint Induced Movement Therapy (CIMT)
Number of subjects: 16
Study 32964537 — intervention group
Group type: EXPERIMENTAL
Intervention: Serelaxin treatment
Number of subjects: 6112
Study 32964537 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic responsiveness
Number of subjects: 6112
Study 32964537 — intervention group
Group type: EXPERIMENTAL
Intervention: LVEF quartile Q4 (LVEF >50%)
Number of subjects: 6112
Study 32964537 — intervention group
Group type: EXPERIMENTAL
Intervention: LVEF quartiles
Number of subjects: 6112
Study 32964537 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients in upper three LVEF quartiles with WRF
Number of subjects: 6112
Study 32964537 — intervention group
Group type: COMPARATOR
Intervention: Patients in lowest LVEF quartile
Number of subjects: 6112
Study 34710395 — intervention group
Group type: EXPERIMENTAL
Intervention: French‐contingent learning group (active sucking on a sensor‐equipped pacifier to infant‐directed French lullabies and readings)
Number of subjects: 41